The pathogenesis of Burkitt's lymphomaMAGRATH, I.Advances in cancer research. 1990, Vol 55, pp 133-270, issn 0065-230X, 138 p.Article

UNDIFFERENTIATED LYMPHOMA CELLS RESPOND TO PWM IN THE PRESENCE OF THEOPHYLLINE OR HELPER T CELLSBENJAMIN D; MAGRATH I.1982; CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY; ISSN 0090-1229; USA; DA. 1982; VOL. 25; NO 3; PP. 316-324; BIBL. 15 REF.Article

Appendix: Selected epidemiological data pertinent to topics discussed in this volume = Appendice: Sélection de données épidémiologiques pertinentes sur les sujets abordés dans ce volumeMAGRATH, I.Progress in cancer research and therapy. 1984, Vol 27, pp 379-386, issn 0145-3726Article

African Burkitt's lymphoma : history, biology, clinical features, and treatmentMAGRATH, I. T.The American journal of pediatric hematology/oncology. 1991, Vol 13, Num 2, pp 222-246, issn 0192-8562Article

Targeted approaches to cancer therapyMAGRATH, I. T.International journal of cancer. 1994, Vol 56, Num 2, pp 163-166, issn 0020-7136Article

INDUCTION OF COMPLEMENT RECEPTOR EXPRESSION IN CELL LINES DERIVED FROM HUMAN UNDIFFERENTIATED LYMPHOMAS. I: MODE OF ACTION OF THEOPHYLLINE AND INHIBITION BY CERTAIN PURINESMAGRATH I; FREEMAN C; NOVIKOVS L et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 127; NO 3; PP. 1034-1038; BIBL. 28 REF.Article

Malignant non-Hodgkin's lymphomas in childrenMAGRATH, I. T.Hematology/oncology clinics of North America. 1987, Vol 1, Num 4, pp 577-602, issn 0889-8588Article

A MULTIDISCIPLINARY APPROACH TO NON-HODGKIN'S LYMPHOMASBERARD CW; GREENE MH; JAFFE ES et al.1981; AM. INTERN. MED.; ISSN 0003-4819; USA; DA. 1981; VOL. 94; NO 2; PP. 218-235; BIBL. 162 REF.Article

DRUG-INDUCED CHANGES IN DNA FLUORESCENCE INTENSITY DETECTED BY FLOW MICROFLUOROMETRY AND THEIR IMPLICATIONS FOR ANALYSIS OF DNA CONTENT DISTRIBUTIONS.ALABASTER O; TANNENBAUM E; HABBERSETT MC et al.1978; CANCER. RES.; U.S.A.; DA. 1978; VOL. 38; NO 4; PP. 1031-1035; BIBL. 40 REF.Article

ANTIBODIES TO EPSTEIN-BARR-VIRUS ANTIGENS BEFORE AND AFTER THE DEVELOPMENT OF BURKITT'S LYMPHOMA IN A PATIENT TREATED FOR HODGKIN'S DISEASE = ANTICORPS DIRIGES CONTRE LES ANTIGENES DU VIRUS EPSTEIN-BARR AVANT ET APRES LE DEVELOPPEMENT D'UN LYMPHOME DE BURKITT CHEZ UN PATIENT TRAITE POUR UNE MALADIE DE HODGKINMAGRATH I; HENLE W; OWOR R et al.1975; NEW ENGL. J. MED.; U.S.A.; DA. 1975; VOL. 292; NO 12; PP. 621-623; BIBL. 20REF.Article

Cancer in developing countries : opportunity and challengeMAGRATH, I; LITVAK, J.Journal of the National Cancer Institute. 1993, Vol 85, Num 11, pp 862-874, issn 0027-8874Article

Localization of breakpoints by polymerase chain reactions in burkitt's lymphoma with 8;14 translocationsSHIRAMIZU, B; MAGRATH, I.Blood. 1990, Vol 75, Num 9, pp 1848-1852, issn 0006-4971, 5 p.Article

FC IGM RECEPTORS ON HUMAN LYMPHOBLASTOID B CELL LINES.PICHLER WJ; BRODER S; MUUL L et al.1978; EUROP. J. IMMUNOL.; GERM.; DA. 1978; VOL. 8; NO 4; PP. 274-278; BIBL. 16 REF.Article

Dual reporter vectors for determination of activity of bidirectional promotersJAIN, V. K; MAGRATH, I. T; SHIMADA, T et al.BioTechniques. 1992, Vol 12, Num 5, pp 681-684, issn 0736-6205, 3 p.Article

The molecular analysis of chromosomal translocations as a diagnostic, epidemiological and potentially prognostic tool in lymphoid neoplasiaMAGRATH, I; BARRIGA, F; MCMANAWAY, M et al.Journal of virological methods. 1988, Vol 21, Num 1-4, pp 275-289, issn 0166-0934Conference Paper

CHILDHOOD HODGKIN'S DISEASE IN UGANDA. A TEN YEAR EXPERIENCEOLWENY CLM; KATONGOLE MBIDDE E; KIIRE C et al.1978; CANCER; USA; DA. 1978; VOL. 42; NO 2; PP. 787-792; BIBL. 24 REF.Article

Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsiesGUTIERREZ, M. I; BHATIA, K; MAGRATH, I et al.Leukemia research. 1993, Vol 17, Num 3, pp 285-289, issn 0145-2126Article

Expression of surface antigens during the cell cycle in different growth phases of American and African Burkitt's lymphoma cell linesSIEVERTS, H; ALABASTER, O; GOLDSCHMIDTS, W et al.Cancer research (Baltimore). 1986, Vol 46, Num 3, pp 1182-1188, issn 0008-5472Article

Jaw involvement in american Burkitt's lymphoma = Atteinte maxillaire dans le lymphome de Burkitt américainSARIBAN, E; DONAHUE, A; MAGRATH, I. T et al.Cancer. 1984, Vol 53, Num 8, pp 1777-1782, issn 0008-543XArticle

A CASE OF PROXIMAL 14 TRISOMY WITH PATHOLOGICAL FINDINGSCOTTRALL K; MAGRATH I; BOOTES JAH et al.1981; J. MENT. DEFIC. RES.; ISSN 0022-264X; GBR; DA. 1981; VOL. 25; NO 1; PP. 1-7; BIBL. 15 REF.Article

PROGNOSTIC FACTORS IN BURKITT'S LYMPHOMA: IMPORTANCE OF TOTAL TUMOR BURDENMAGRATH I; LEE YJ; ANDERSON T et al.1980; CANCER; USA; DA. 1980; VOL. 45; NO 6; PP. 1507-1515; BIBL. 25 REF.Article

Non-Hodgkin's lymphomaSHAD, A; MAGRATH, I.The Pediatric clinics of North America. 1997, Vol 44, Num 4, pp 863-890, issn 0031-3955Article

A novel mutation in the p53 gene in a Burkitt's lymphoma cell lineKISHOR BHATIA; GUTIERREZ, M. I; MAGRATH, I. T et al.Human molecular genetics (Print). 1992, Vol 1, Num 3, pp 207-208, issn 0964-6906Article

A chemiluminescent assay for quantitation of β-galactosidase in the femtogram range : application to quantification of β-galactosidase in lacZ-transfected cellsJAIN, V. K; MAGRATH, I. T.Analytical biochemistry. 1991, Vol 199, Num 1, pp 119-124, issn 0003-2697Article

INDUCTION OF COMPLEMENT RECEPTOR EXPRESSION IN CELL LINES DERIVED FROM HUMAN UNDIFFERENTIATED LYMPHOMAS. II: CHARACTERIZATION OF THE INDUCED COMPLEMENT RECEPTORS AND DEMONSTRATION OF THE SIMULTANEOUS INDUCTION OF EBV RECEPTORMAGRATH I; FREEMAN C; SANTAELLA M et al.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 127; NO 3; PP. 1039-1043; BIBL. 20 REF.Article